DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of “Reduce” from Analysts

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has received a consensus recommendation of “Reduce” from the fifteen analysts that are presently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have given a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $15.1538.

A number of equities analysts have issued reports on the stock. Barrington Research reaffirmed an “outperform” rating and set a $14.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, December 16th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, October 28th. Evercore ISI reduced their target price on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a report on Wednesday, October 8th. Finally, Mizuho set a $13.00 price target on DENTSPLY SIRONA in a report on Friday, November 7th.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier sold 82,200 shares of the stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.50% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in XRAY. Allworth Financial LP increased its stake in shares of DENTSPLY SIRONA by 66.6% during the 3rd quarter. Allworth Financial LP now owns 10,323 shares of the medical instruments supplier’s stock worth $131,000 after purchasing an additional 4,127 shares during the last quarter. Caerus Investment Advisors LLC purchased a new stake in DENTSPLY SIRONA in the third quarter worth $153,000. Caitong International Asset Management Co. Ltd increased its position in DENTSPLY SIRONA by 337.9% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after buying an additional 2,122 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its stake in shares of DENTSPLY SIRONA by 662.0% in the third quarter. Jacobs Levy Equity Management Inc. now owns 4,608,341 shares of the medical instruments supplier’s stock valued at $58,480,000 after buying an additional 4,003,606 shares during the period. Finally, Morningstar Investment Management LLC purchased a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at $3,606,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $11.31 on Friday. The firm has a market capitalization of $2.26 billion, a P/E ratio of -2.56, a P/E/G ratio of 0.82 and a beta of 1.01. DENTSPLY SIRONA has a 52 week low of $9.85 and a 52 week high of $20.59. The stock has a 50 day moving average price of $11.56 and a two-hundred day moving average price of $13.48. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.08). The company had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a negative net margin of 24.34% and a positive return on equity of 17.10%. The firm’s quarterly revenue was down 4.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.50 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Equities analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 9th. Stockholders of record on Friday, December 26th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.7%. The ex-dividend date is Friday, December 26th. DENTSPLY SIRONA’s payout ratio is presently -14.48%.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.